Bayesian inference on protective antibody levels using case-control data

被引:19
作者
Carey, VJ
Baker, CJ
Platt, R
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77025 USA
[3] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77025 USA
关键词
Bayesian estimation and inference; immunoepidemiology; sensitivity analysis; vaccine design;
D O I
10.1111/j.0006-341X.2001.00135.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the study of immune responses to infectious pathogens, the minimum protective antibody concentration (MPAC) is a quantity of great interest. We use case-control data to estimate the posterior distribution of the conditional risk of disease given a lower bound on antibody concentration in an at-risk subject. The concentration bound beyond which there is high credibility that infection risk is zero or nearly so is a candidate for the MPAC. A very simple Gibbs sampling procedure that permits inference on the risk of disease given antibody level is presented. In problems involving small numbers of patients, the procedure is shown to have favorable accuracy and robustness to choice/misspecification of priors. Frequentist evaluation indicates good coverage probabilities of credibility intervals for antibody-dependent risk, and rules for estimation of the MPAC are illustrated with epidemiological data.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 15 条
[1]   A hierarchical Bayesian model to predict the duration of immunity to Haemophilus influenzae type b [J].
Auranen, K ;
Eichner, M ;
Käyhty, H ;
Takala, AK ;
Arjas, E .
BIOMETRICS, 1999, 55 (04) :1306-1313
[2]   CORRELATION OF MATERNAL ANTIBODY DEFICIENCY WITH SUSCEPTIBILITY TO NEONATAL GROUP-B STREPTOCOCCAL INFECTION [J].
BAKER, CJ ;
KASPER, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (14) :753-756
[3]   METHODS OF INFERENCE FOR ESTIMATES OF ABSOLUTE RISK DERIVED FROM POPULATION-BASED CASE-CONTROL STUDIES [J].
BENICHOU, J ;
GAIL, MH .
BIOMETRICS, 1995, 51 (01) :182-194
[4]  
Chambers JM., 1983, WADSWORTH
[5]  
KAYHTY H, 1983, J INFECT DIS, V147, P1100
[6]   Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization [J].
Klugman, KP ;
Koornhof, HJ ;
Robbins, JB ;
LeCam, NN .
VACCINE, 1996, 14 (05) :435-438
[7]   A STUDY OF LOGSPLINE DENSITY-ESTIMATION [J].
KOOPERBERG, C ;
STONE, CJ .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1991, 12 (03) :327-347
[8]   Estimation of absolute risk from nested case-control data [J].
Langholz, B ;
Borgan, O .
BIOMETRICS, 1997, 53 (02) :767-774
[9]  
Paoletti LC, 2000, GRAM-POSITIVE PATHOGENS, P137
[10]  
Raftery AE., 1996, Markov chain Monte Carlo in practice, P115